NCT06753812

Brief Summary

Lower extremity constraint induced movement therapy has been applied to individuals with multiple sclerosis, stroke, subacute and chronic hemiparesis in recent years and positive results have been reported. However, there is no study in the literature regarding the application of this treatment method to the pediatric population. In order to address this gap in the literature, we planned to conduct this study to examine the possible effects of lower extremity constraint induced movement therapy on lower extremity functions, balance and gait parameters in individuals with cerebral palsy.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
36

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jan 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
enrolling by invitation

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 23, 2024

Completed
8 days until next milestone

First Posted

Study publicly available on registry

December 31, 2024

Completed
15 days until next milestone

Study Start

First participant enrolled

January 15, 2025

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 30, 2025

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2025

Completed
Last Updated

December 31, 2024

Status Verified

December 1, 2024

Enrollment Period

5 months

First QC Date

December 23, 2024

Last Update Submit

December 23, 2024

Conditions

Keywords

cerebral palsySurface Electromiyographylower extremity

Outcome Measures

Primary Outcomes (1)

  • Surface EMG

    Electromyography is a method used to record and analyze myoelectric signals; it provides information about the transfer of the signals to the neuromuscular junction, the electrical activation of muscle cells in the motor unit, muscular contraction and relaxation strategies and activation time. sEMG measurements made on the individual's skin using superficial electrodes are frequently preferred for research purposes because they are non-invasive and painless. In sEMG application, electrodes are usually placed in the center of the muscle body for large superficial muscles and on the target muscle for small muscles. The maximal voluntary isometric contraction (MVIC) value of the muscles will be calculated and recorded with electromyographic evaluation in the individuals participating in the study. The results of the pre-evaluation and post-evaluation will be compared. The muscle groups to be evaluated within the scope of our study are M. Rectus Femoris and M. Gastrocnemius.

    6 weeks

Secondary Outcomes (13)

  • Modified Tardieu Scale

    6 weeks

  • Gross Motor Function Measure (GMFM-88 Dimensions D and E)

    6 weeks

  • Selective Control Assessment of the Lower Extremity- SCALE

    6 weeks

  • Observational Gait Analysis-OGS

    6 weeks

  • Gross Motor Function Classification System

    6 weeks

  • +8 more secondary outcomes

Study Arms (2)

Constraint induced movement therapy group

ACTIVE COMPARATOR

Children in this group will receive constraint induced movement therapy in addition to conventional physical therapy twice a week.

Other: constraint induced movement therapy

Control group

OTHER

Children in this group will continue to receive their treatment twice a week at the special education and rehabilitation center where they are currently registered and attending.

Other: Control (Standard treatment)

Interventions

Children in this group will receive constraint induced movement therapy for 10 sessions over 2 weeks, each session lasting 90 minutes, in addition to the treatment they receive 2 days a week at the special education and rehabilitation centers they attend.

Constraint induced movement therapy group

Children in this group will continue to receive their treatment at the special education and rehabilitation center they attend, two days a week for 40 minutes.

Control group

Eligibility Criteria

Age5 Years - 15 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Having been diagnosed with Cerebral Palsy by a Child Neurologist.
  • Having been classified as Unilateral Cerebral Palsy according to SCPE.
  • Being between the ages of 5-15,
  • Being at levels I-II according to the Gross Motor Function Classification System
  • Being at levels I-II according to the Communication Function Classification System
  • Being able to stand up from sitting independently, even with the help of the upper extremity
  • Being able to walk at least 10 m with or without an assistive device

You may not qualify if:

  • Children who have had lower extremity orthopedic surgery within the last six months
  • Children who have had lower extremity Botox injections within the last six months
  • Those with rigid contractures involving lower extremity joints,
  • Children with levels III-IV according to the Communication Functions Classification System
  • Families and children who do not accept full participation in treatment

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Bolu Abant İzzet Baysal University Faculty of Health Sciences

Bolu, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Cerebral Palsy

Interventions

Constraint Induced Movement Therapy

Condition Hierarchy (Ancestors)

Brain Damage, ChronicBrain DiseasesCentral Nervous System DiseasesNervous System Diseases

Intervention Hierarchy (Ancestors)

Exercise TherapyPhysical Therapy ModalitiesTherapeuticsRehabilitation

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: 2 groups with a conventional therapy control group
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

December 23, 2024

First Posted

December 31, 2024

Study Start

January 15, 2025

Primary Completion

May 30, 2025

Study Completion

June 30, 2025

Last Updated

December 31, 2024

Record last verified: 2024-12

Data Sharing

IPD Sharing
Will not share

Locations